Across much of Canada, the distinct crispness of chill air marks an unmistakable shift in seasons—a shift that unavoidably brings a change in health risks and signals the advent of the cold and flu season. After enduring three harsh winters where respiratory illnesses commanded the headlines and crowded hospitals, physicians remain hopeful for a less tumultuous season this time around.
Going by Dr. Gerald Evans’ observations, fear is palpable in the face of past experiences. Dr. Gerald, who presides over the division of infectious diseases at Queen’s University in Kingston, Ontario, recalled the grim incident of last year when influenza, COVID, and respiratory syncytial virus (RSV) peaked simultaneously. However, he expressed a cautious optimism for the current year, wherein such a grim scenario might not be replicated.
Although an early flu season is anticipated, data from the southern hemisphere paint a promising picture of less severity. Nevertheless, with increasing cases of COVID-19 and RSV, medical practitioners are urging people—particularly those above 60 and with underlying health issues—to take a proactive approach to their health and get vaccinated. The elderly population is especially vulnerable to severe health setbacks, and vaccinations serve as an indispensable tool for illness prevention.
Dr. Evans points out that these infections’ impact extends beyond respiratory complications—they also exacerbate other health conditions, including heart ailments like heart attacks and heart failure.
This fall, Canadians have access to four primary vaccines, each targeting a particular virus or bacteria historically responsible for heightened hospitalizations and fatalities within vulnerable populations. Health practitioners are encouraging the uptake of immunizations for COVID-19, influenza, bacterial pneumonia, and RSV—recently approved by Health Canada.
While the COVID and flu vaccines are typically available for free at most doctor’s offices, pharmacies, and public health units, other vaccinations can come with costs. For instance, the price of pneumonia vaccines depends on the product and province. Most provinces provide at least one type of immunization for certain demographics, while other types can be purchased. The immunization costs for the recently approved RSV vaccine, unfortunately, have to be borne by most seniors across the country.
The complexity and newness of these vaccines present a unique challenge. As Dr. Evans explains, a broader acceptance and rollout of these vaccinations are contingent on provincial approvals and funding. The sole exception seems to be Ontario, where the RSV vaccine will be covered for seniors aged 60 and older residing in long-term care facilities or certain retirement homes.
The efficacy of the new RSV vaccine has been impressive, boasting a success rate of over 82 per cent for the prevention of lower respiratory tract diseases in older adults, and over 94 per cent in those with underlying medical conditions.
Given the complexity of these numerous vaccinations, it’s understandable that some may find it confusing. Thus, health professionals are urging everyone to consult with their doctor or pharmacist for guidance.
Kyro Maseh, a pharmacist at Rylander Pharmacy in Toronto, emphasizes the importance of dialogue as we enter this year’s respiratory illness season. He asserts that the uptake of vaccines has been reasonably good this season.
Reflecting on the aftermath of last winter, Maseh states, “We’ve seen the devastating effects of out-of-control respiratory illnesses on overall hospital capacity.” This reality, he believes, has prompted many to turn to vaccines for personal and community protection.
